(c) 2024 PillSync.com

metoclopramide metoclopramide hydrochloride 5 mg tablet

INDICATIONS AND USAGE The use of metoclopramide tablets is recommended for adults only. Therapy should not exceed 12 weeks in duration. Symptomatic gastroesophageal reflux: Metoclopramide tablets are indicated as short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy. The principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms. If symptoms are confined to particular situations, such as following the evening meal, use of metoclopramide as single doses prior to the provocative situation should be considered, rather than using the drug throughout the day. Healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12-week trial using doses of 15 mg q.i.d. As there is no documented correlation between symptoms and healing of esophageal lesions, patients with documented lesions should be monitored endoscopically. diabetic gastroparesis (Diabetic Gastric Stasis): Metoclopramide tablets are indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis. The usual manifestations of delayed gastric emptying (e.g., nausea, vomiting, heartburn, persistent fullness after meals and anorexia) appear to respond to metoclopramide within different time intervals. Significant relief of nausea occurs early and continues to improve over a three-week period. Relief of vomiting and anorexia may precede the relief of abdominal fullness by one week or more.

american health packaging

10 years ago ROUND WHITE BL 92 metoclopramide metoclopramide hydrochloride 5 mg tablet


HOW SUPPLIED 10 mg — Each white, round tablet imprinted with on one side and 269 and bisect on the other side contains 10 mg of metoclopramide (as the hydrochloride). Tablets are supplied in unit dose packages of 100 (10x10) (NDC 68084-091-01). Store at 20°-25°C (68° – 77°F) (See USP Controlled Room Temperature). PACKAGING INFORMATION American Health Packaging unit dose blisters (see How Supplied section) contain drug product from Actavis Elizabeth LLC as follows: (10 mg / 100 UD) NDC 68084-091-01 packaged from NDC 0228-2269 Packaged and Distributed by: American Health Packaging Columbus, OH 43217 8001101/0612 imprint

More pills like ROUND BL 92


"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site